title: 308-nm excimer laser for the treatment of psoriasis: induration-based dosimetry.
abstract: OBJECTIVE
  To determine the response of stubborn psoriatic plaques to the 308-nm excimer laser.
  
  
  METHODS
  Controlled study with a before-after design.
  
  
  METHODS
  A university-based clinical research center.
  
  
  METHODS
  Adult subjects with recalcitrant plaque psoriasis that have not responded to other therapies for at least 2 months.
  
  
  METHODS
  Selected psoriatic plaques were treated with the 308-nm excimer laser. One lesion was left as a control. Each plaque was treated 2 times a week, with an initial dose based solely on the induration component of the modified Psoriasis Area and Severity Index score for that lesion. Subsequent treatments were twice a week with dosage increments up to 50%, based on the change in induration. Four final consolidation doses were given once the induration score was reduced to zero.
  
  
  RESULTS
  Eighteen subjects were treated. There were 4 dropouts because of various scheduling problems. In the remaining 14 subjects, 44 plaques received a mean of 10 treatments (range, 4-14). Treatments were quick and well tolerated. The mean cumulative dose was 8.8 J/cm2 (range, 2.2-22.8 J/cm2). Compared with controls, treated plaques showed significant improvement (P<.001). The only adverse event was a mild sunburn-like reaction in 2 subjects after 1 treatment.
  
  
  CONCLUSIONS
  Selective targeting of laser-generated 308-nm excimer radiation with this convenient subblistering dosage schedule based on induration allows for individualized treatment plans for each plaque. Clearing of stubborn psoriatic lesions occurs rapidly and safely.
authors.affiliation: Gange Photomedicine Research Center, Department of Dermatology, Harvard Medical School, Massachusetts General Hospital, Boston 02114, USA.
authors.forename: Atul
authors.initials: A
authors.lastname: Taneja
authors.forename: Manju
authors.initials: M
authors.lastname: Trehan
authors.forename: Charles R
authors.initials: CR
authors.lastname: Taylor
mesh_terms: D000328:Adult; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D053685:Laser Therapy; D028022:Low-Level Light Therapy; D008297:Male; D017063:Outcome Assessment, Health Care; D011565:Psoriasis / Q000473:pathology / Q000532:radiotherapy*; D011874:Radiometry; D012008:Recurrence; D012720:Severity of Illness Index; D013997:Time Factors